Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 1

Correlation between the Diagnostic Yield from the Bronchoalveolar Lavage Fluid Analysis and Clinicoradiological Findings in Sarcoidosis

Pages
21–26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The diagnostic role of BALF is greater in patients withextrapulmonary involvement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: The diagnosis of sarcoidosis is frequently challenging, requiring a search for less invasive, more reliable diagnostic methods.
📊
Key Findings & Data:The bronchoalveolar lavage fluid (BALF) analysis has been used in the differential diagnosis of sarcoidosis for many years with awide sensitivity and specificity rates.
💡
Conclusion & Impact:The diagnostic role of BALF is greater in patients withextrapulmonary involvement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: The diagnosis of sarcoidosis is frequently challenging, requiring a search for less invasive, more reliable diagnostic methods. The bronchoalveolar lavage fluid (BALF) analysis has been used in the differential diagnosis of sarcoidosis for many years with awide sensitivity and specificity rates. The objective of the study is to investigate whether diagnostic performance of the BALF analysis isaltered by clinicoradiological findings of patients with sarcoidosis.MATERIALS AND METHODS: The present study is a retrospective, single-center, observational study, designed in a sarcoidosis outpatientclinic in a training hospital. Patients who had undergone the bronchoalveolar lavage BAL procedure at diagnosis were included in thestudy. Demographics, clinical and detailed chest X-ray, and high-resolution computed tomography (HRCT) findings at diagnosis wererecorded. According to the diagnostic performance, the BALF results were grouped as “diagnostic” and “non-diagnostic,” and recordedparameters were compared between the groups.RESULTS: Considering the BALF analysis of all the 257 patients, the mean lymphocyte ratio was 41±17.5 (5–80), and the mean CD4/CD8was 5.5±4.7 (0.1–24.7). The BALF analysis was diagnostic in 56% (n=145) of patients. Diagnostic performance of the procedure did notcorrelate with any of the demographic data, smoking status, spirometric findings, chest X-ray staging, HRCT findings, and tomographyscoring. Extrapulmonary involvement was significantly more frequent in the diagnostic group (66% vs. 34%, p=0.006).CONCLUSION: BALF results signal sarcoidosis in more than half of the patients. The diagnostic role of BALF is greater in patients withextrapulmonary involvement.

🔖

Cite This Article

AKYIL, F. T., AĞCA, M., ÖZTÜRK, H., SONKAYA, E., ERDEM, İ., BÜLBÜL, E. U., ÖZBAKİ, F., YILDIZ, R., BEKİR, S. A., SEVİM, T. (2020). Correlation between the Diagnostic Yield from the Bronchoalveolar Lavage Fluid Analysis and Clinicoradiological Findings in Sarcoidosis. Turkish Thoracic Journal, Cilt: 21 - Sayı: 1, 21–26. https://ajindex.com/articles/417911

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. American Thoracic Society/European Respiratory Society/ World Association Sarcoidosis and Other Granulomatous Disorders. Statement on Sarcoidosis. Am J Respir Crit Care Med 1999
  2. [CrossRef] 2. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003
  3. [CrossRef] 3. Costabel U. CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur Respir J 1997
  4. [CrossRef] 4. Hyldgaard C, Kaae S, Riddervold M, et al. Value of s-ACE, BAL lymphocytosis, and CD4+/CD8+ and CD103+CD4+/CD4+ Tcell ratios in diagnosis of sarcoidosis. Eur Respir J 2012
  5. [CrossRef] 5. Shen Y, Pang C, Wu Y, et al. Diagnostic performance of bronchoalveolar lavage fluid CD4/CD8 ratio for sarcoidosis: A metaanalysis. EBioMedicine 2016
  6. [CrossRef] 6. Marruchella A., Tondini M. Reliability of bronchoalveolar lavage in the routine clinical assessment of patients with sarcoidosis. A retrospective analysis. Panminerva Med 2002
  7. Greco S, Marruchella A, Massari M, Saltini C. Predictive value of BAL cellular analysis in differentiating pulmonary tuberculosis and sarcoidosis. Eur Respir J 2005
  8. [CrossRef] 8. Lee W, Chung WS, Hong KS, Huh J. Clinical usefulness of bronchoalveolar lavage cellular analysis and lymphocyte subsets in diffuse interstitial lung diseases. Ann Lab Med 2015
  9. [CrossRef] 9. Urbankowski T, Knyziak-Medrzycka I, Domagała-Kulawik J, Chazan R. Sarcoidosis and tobacco smoking--clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition. Pol Merkur Lekarski 2012
  10. Hoser G, Kawiak J, Domagała-Kulawik J, et al. Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol 1999
  11. Danila E, Jurgauskiene L, Malickaite R. BAL fluid cells and pulmonary function in different radiographic stages of newly diagnosed sarcoidosis. Adv Med Sci 2008
  12. [CrossRef] 12. Danila E, Jurgauskiene L, Norkuniene J, Malickaite R. BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity. Ups J Med Sci 2009
  13. [CrossRef] 13. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001
  14. [CrossRef] 14. Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung dise